Literature DB >> 20591527

Angiotensin converting enzyme inhibitor or angiotensin II receptor blocker for the prevention of type 2 diabetes mellitus?

Ching-Chu Chen, An-Na Chiang, Min-Huang Hsieh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20591527     DOI： 10.1016/j.diabres.2010.05.028

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


× No keyword cloud information.
  2 in total

1.  Different angiotensin receptor blockers and incidence of diabetes: a nationwide population-based cohort study.

Authors:  Chia-Hsuin Chang; Yi-Cheng Chang; Li-Chiu Wu; Jou-Wei Lin; Lee-Ming Chuang; Mei-Shu Lai
Journal:  Cardiovasc Diabetol       Date:  2014-05-14       Impact factor: 9.951

2.  Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15,990 patients.

Authors:  L P Hasvold; J Bodegård; M Thuresson; J Stålhammar; N Hammar; J Sundström; D Russell; S E Kjeldsen
Journal:  J Hum Hypertens       Date:  2014-06-26       Impact factor: 3.012
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.